Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
Niparuck
Pimjai
P
Kanoksil
Wasana
W
Chuncharunee
Suporn
S
Boonsakan
Paisarn
P
Ungkanont
Artit
A
Angchaisuksiri
Pantep
P
Karntisaviwat
Kanlaya
K
Apilugsanachit
Axara
A
Rerkamnuatchoke
Budsaba
B
Jootar
Saengsuree
S
Nitiyanant
Prawat
P
Atichartakarn
Vichai
V
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology; D011379:Prognosis; D012189:Retrospective Studies; D013785:Thailand / Q000453:epidemiology; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055815:Young Adult
D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine